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Edited by Masayuki MiyasakaAbstract In this study, we examined whether interleukin-18
(IL-18) aﬀects natural killer (NK) cells’ migration and matrix
metalloproteinases (MMPs) production. We demonstrated that
chemotaxis of human NK cells through basement membrane-like
Matrigel was augmented by IL-18. As well, IL-18 stimulation
induces the production of activated forms of matrix metallopro-
teinase-2 (MMP-2) as well as the production of pro-MMP-2 from
NK cells. We also demonstrated that MT1-MMP expression on
human NK cells, which is a major activator of MMP-2, was
induced by IL-18 stimulation coordinated with MMP-2 activa-
tion. These data suggest that the MT1-MMP/MMP-2 system
participates in the degradation of basement membrane compo-
nents and thus contributes to NK cell migration.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Matrix metalloproteinases (MMPs) are a family of zinc
endo-proteinases that are a secreted or membrane-bound form
of protein [1,2]. They play important roles in many biological
processes including angiogenesis, inﬂammation and cancer
metastasis [3–5]. The main characteristics of MMPs is the
degradation of the extracellular matrix of basement mem-
branes, thus enabling cells to invade into tissues [6–8]. For
example, T cells secrete the gelatinases, MMP-2 and MMP-9 in
response to cytokines and inﬂammatory mediators and mi-
grate across basement membrane by degrading extracellular
matrix (ECM) using gelatinases [9–11].
Natural killer (NK) cells are endowed with the ability to
express spontaneous cytotoxicity against tumor cells or virus-
infected cells [12]. Upon several biological responses such as
virus infection and carcinogenesis, NK cells encompass* Corresponding author. Fax: +81-957-54-0292.
E-mail address: migita@nmc.hosp.go.jp (K. Migita).
Abbreviations: IL-18, interleukin-18; MMPs, matrix metalloprotein-
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possess proteinases which mediate their transmigration
through the ECM component for their migration to the target
cells [16–18]. Recent studies have suggested that matrix me-
talloproteinases play an important role in basement membrane
degradation and the transmigration of NK cells [19]. The 92
kDa gelatinase (gelatinase B, MMP-9) and the 72 kDa gela-
tinase (gelatinase A, MMP-2), which eﬃciently degrade native
collagen type 4 and 5, are believed to play an important role in
lymphocyte migration [20]. Recently, membrane-type MMP
(MT-MMP) has been shown to be a potent activator of MMP-
2 by cleaving the propeptide domain [21,22]. It has also been
demonstrated that IL-2 activated NK cells produce MMP-2
and MMP-9 and express MT-MMP [23,24]. Therefore, IL-2
augments NK cells’ migration as well as NK cells’ cytotoxicity.
IL-18 is also essential for NK cells’ cytotoxicity and antitumor
activity [25,26]. It is probable that IL-18 augments NK cells’
migratory ability by producing MMPs in addition to its cy-
totoxicity. In order to identify the contribution of IL-18 on
NK cells’ migratory function, we examined the MMPs and
MT-MMPs produced by IL-18-stimulated human NK cells.2. Materials and methods
2.1. Reagents
Recombinant human IL-18 was purchased from MBL (Nagoya, Ja-
pan). Endotoxin levels were less than 0.1 ng per 1 mg recombinant IL-18
protein. Recombinant human IL-12 was purchased from Genzyme
(Cambridge,MA). Recombinant human IL-2 was kindly provided from
Shionogi Pharmaceutical Co. (Osaka, Japan). Anti-human IL-18 neu-
tralizing monoclonal antibodies (125-2H) were purchased from MBL.
Anti-human IL-2 neutralizing monoclonal antibodies (5334.21) were
purchased fromGenzyme. Anti-human IFN-c neutralizing monoclonal
antibodies (NIB42)were purchased fromeBioscience (SanDiego,USA).
2.2. Isolation of NK cells
NK cells were puriﬁed from buﬀy coat cells (kindly provided by the
Nagasaki Red Cross Blood Center, Nagasaki, Japan) isolated from
peripheral blood, as previously described [27]. Brieﬂy, peripheral blood
mononuclear cells (PBMC) were separated from whole blood by cen-
trifugation over Ficoll–Hypaque. For NK cell isolation, cells were de-
pleted of T lymphocytes, B lymphocytes, and macrophages/monocytes
using a NK cell isolation kit (Minitenyi Biotec, Bergisch Galdbach,
Germany), including bead-coupled mAb against CD3, CD4, CD19,
and CD33. Using a MACS magnetic separator (Miltenyi Biotec), NK
cells were puriﬁed phenotypically>95% CD16þ CD56þ, as determined
by ﬂow cytometry. Freshly isolated NK cells were cultured with serum-
free media (RPMI 1640), with or without IL-18, at a concentration of
1 106 cells/ml in 24-well plates (Costar, Cambrige, MA).blished by Elsevier B.V. All rights reserved.
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Cells migration was quantiﬁed using Transwell inserts (6.5 lm;
Costar, Cambridge, MA) ﬁtted with polycarbonate ﬁlters (8-lm pre
size; Nuclepore Corp., Pleasanton, CA). The upper sides of the
ﬁlter were coated with Matrigel (200 lg/cm2, Collaborative Re-
search Inc, Bedford, MA) and dried overnight. NK cells (5 106 in
1000 ll medium) were added to the upper compartment of the
insert with or without IL-18. The lower compartment contained
1500 ll of medium containing identical concentrations of IL-18.
The chambers were incubated at 37 C for 24 h. Then, the numbers
of NK cells that had migrated into the lower chamber were
counted.2.4. Gelatin zymography
Culture media were incubated at 37 C for 20 min in sodium dodecyl
sulfate (SDS) sample buﬀer free of reducing agents and then electro-
phoresed on 8% polyacrylamide gels containing 0.5% gelatin at 4 C.
After electrophoresis, the gels were washed in 2.5% Triton-X 100 to
remove SDS and incubated with 50 mM Tris–HCl buﬀer (pH 7.5)
containing 0.15 M NaCl, 10 mM CaCl2, and 0.02% NaN3 for 16 h at
37 C, and then stained with 0.1% Coomassie Blue R250. The gela-
tinolytic bands were analyzed by densitometer (Photometrics, Tucson,
Arizona). Images from densitometer were transferred to a personal
computer and analyzed using IPLab Gel software (Signal Analytics
Corporation, Vienna, VA).2.5. Immunoblot analysis
The expression of MT-MMP on NK cells and the secretions of
tissue inhibitor of MMPs (TIMPs) from NK cells were analyzed by
immunoblot. For this purpose, cells were washed with cold PBS and
lysed by the addition of a lysis buﬀer containing 1% Nonidet P-40, 50
mM Tris (pH 7.5), 100 mM NaCl, 5 mM EDTA, 10 lg/ml aprotinin,
and 10 lg/ml leupeptin for 20 min at 4 C. Insoluble material was
removed by centrifugation at  1500 g for 15 min at 4 C. The su-
pernatant was saved and the protein concentration was determined
using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). An
identical amount of protein (30 lg) from each lysate or culture su-
pernatant was subjected to 10% SDS–polyacrylamide gel electro-
phoresis. The fractionated proteins were transferred to nitrocellulose
membranes (Amersham, Arlington Heights, IL), and the ﬁlters were
blocked for 1.5 h using non-fat dried milk in Tris-buﬀered saline
(TBS: 50 mM Tris, 0.15 M NaCl, pH 7.5) containing 0.1% Tween 20,
washed with TBS, and incubated at room temperature for 2 h at a
1:150 dilution of mouse anti-MT1, 2, 3-MMP or TIMP-1, 2 mono-
clonal antibodies (Fuji Chemicals, Takaoka, Japan). The membranes
were further incubated with a 1:2000 dilution of horseradish perox-
idase-conjugated donkey anti-mouse immunoglobulin G (IgG) anti-
body (Promega, Madison, WI) for 20 min. An enhanced
chemiluminescence (ECL) system (Amersham) was used for detec-
tion. The ﬁlters were subsequently exposed to ﬁlm for 15 s and the
latter was processed.2.6. RNA preparation and RT-PCR assay
Total cellular RNA was extracted from NK cells using guanidium
thiocyanate and phenol (RNAzol B, Cinna/Biotek Labs Int. Inc.,
Friendswood, TX). First-strand cDNA was synthesized by reverse
transcription at 45 C for 45 min in a 50 ll reaction mixture
containing 1 lg of total RNA and MuLV reverse transcriptase
(Gibco-BRL, Gaithersburg, MD). After denaturing at 99 C for 5
min followed by cooling at 5 C, the cDNA was ampliﬁed using
PCR. Two microliters of denatured cDNA was ampliﬁed by a 20 ll
ﬁnal volume containing 1 U Taq DNA polymerase (Gibco-BRL), 1
lM of each primer, Taq polymerase buﬀer, 1.5 mM MgCl2, and 1.5
mM of each dNTP. PCR was performed in a thermal cycler (Perkin–
Elmer Cetus, Foster City, CA) using a program of 30 cycles of 95 C
for 1 min, 55 C for 1 min, and 72 C for 1 min with a ﬁnal 10 min
extension at 72 C. The ampliﬁed products were subjected to elec-
trophoresis on 2% agarose gel.
The following speciﬁc primers were used for MT1-MMP:
50-AGGCGCCCCCGATGTGGTGTT-30 (forward),
50-TGGCCGAGGGGTCACTGGAATGCT-30 (reverse).




Predicted size of the fragment is 284 bp.3. Results
3.1. Migration of IL-18-stimulated human NK cells
We used a matrigel invasion assay to determine the ability of
IL-18-stimulated human NK cells to invade through a model
basement membrane. Freshly isolated human NK cells were
placed in aMatrigel invasion chamber in the presence or absence
of IL-18 for 24 h. As shown in Fig. 1A, IL-18 enhanced NK cell
mobility signiﬁcantly at respective concentrations of 0–100 ng/
ml. IL-18 may have a capacity to induce IL-2, which has been
shown to augment NK cell migration [11]. Therefore, we ex-
amined the eﬀects of anti-IL-2 antibodies on IL-18-stimulated
NKcellmigration.As shown inFig. 1B, anti-IL-2 antibodies did
not aﬀect IL-18-stimulatedNKcell migratory activity. IL-12 is a
proinﬂammatory cytokine produced by macrophages and aug-
ments NK cell cytotoxicity [28]. We investigated whether IL-12
induces NK cell migration. As shown in Fig. 1C, IL-12 induces
NK cell migration and its migration-inducing activity is similar
to those of IL-18. IL-12 has been shown to enhance IL-18-
mediated biological activity by inducing IL-18R expression [29].
Therefore, we examined the combined eﬀects of IL-12 and IL-18
on NK cell migration. The combined treatments of IL-18 plus
IL-12 upregulates NK cell migratory activity (Fig. 1C).
3.2. Gelatin zymographic analysis of NK cell culture
supernatants
We sought to determine whether or not IL-18 enhances the
MMP secretion necessary to allow NK cells to migrate across
the Matrigel mode basement membrane. Supernatants isolated
from IL-18-stimulated NK cells grown in serum-free media
were analyzed using SDS–PAGE gelatin zymography. The re-
sults indicated two major gelatin-cleaving activities that corre-
spond to the 72-kDa MMP-2 and 92-kDa MMP-9. These two
gelatinolytic bands were increased by IL-18 stimulation
(Fig. 2A). Gelatinases are known to be secreted in a latent form
and converted to the active form through the cleavage of the N-
terminal pro-peptide domain by membrane-type matrix me-
talloproteinase [21,22]. The enzymatic ability of gelatinases is
inﬂuenced by these activation processes. In gelatin zymography
of IL-18-stimulated NK cell culture supernatants, a detectable
gelatinolytic bandwas also noted at about 66 kDa in addition to
the 72 kDaMMP-2. This lower product of 66 kDa corresponds
to the active form ofMMP-2. It is possible that IL-18 stimulates
other cytokines, such as IL-2, production from NK cells. As
shown in Fig. 2B, IL-2 stimulated the gelatinases secretion from
NK cells. To determine whether NK cells secreted gelatinases in
response to IL-18 or indirectly via IL-2, IL-2 was blocked by
anti-IL-2 neutralizing antibodies. Although anti-IL-18 neu-
tralizing antibodies blocked the IL-18-induced secretion of ac-
tivated MMP-2, anti-IL-2 neutralizing antibodies did not aﬀect
this secretion fromNK cells (Fig. 2B and C). IL-18 also induces
IFN-c production from NK cells [30]. To determine whether
IL-18-mediated IFN-c production aﬀects the MMPs secretion
from NK cells, we examined the eﬀects of anti-IFN-antibodies
on IL-18-induced activated MMP-2 secretion. As shown in
Fig. 2D, anti-IFN-c neutralizing antibodies did not aﬀect IL-
18-induced activated MMP-2 secretion from NK cell.
Fig. 1. (A) Eﬀects of IL-18 on human NK cell migration across a
model of basement membrane. Human NK cells (5 106) in 1.0 ml
were placed in the top well of Matrigel invasion chambers with various
concentrations of IL-18 for 24 h. Results are expressed as cell numbers
invaded into bottom chambers through Matrigels. Data for bar graphs
represent meansS.E.M. of three independent experiments. Statistical
signiﬁcance was performed by Student’s t-test. *P < 0:05 versus con-
trol (untreated NK cells). (B) Eﬀects of anti-cytokine antibodies on
NK cell migration across a model of basement membrane. Human NK
cells (5 106) in 1.0 ml were placed in the top well of Matrigel invasion
chambers with IL-18 (100 ng/ml) in the presence or absence of anti-IL-
2 (aIL-2 ﬁnal concentrations; 2 lg/ml) or anti-IL-18 (aIL-18 ﬁnal
concentrations; 10 lg/ml) neutralizing antibodies for 24 h. Results are
expressed as cell numbers invaded into bottom chambers through
Matrigels. Data for bar graphs represent means S.E.M. of two in-
dependent experiments. (C) Combined eﬀects of IL-12 and IL-18 on
NK cell migration across a model of basement membrane. Human NK
cells (5 106) in 1.0 ml were placed in the top well of Matrigel invasion
chambers with IL-18 (100 ng/ml) and IL-12 (10 ng/ml) for 24 h. Results
are expressed as cell numbers invaded into bottom chambers through
Matrigels. Data for bar graphs represent means S.E.M. of two
independent experiments.
Fig. 2. (A) IL-18-induced gelatinase secretion from human NK cells.
Human NK cells were cultured with IL-18 in serum-free culture media
for 24 h. Conditioned media were analyzed by gelatin zymography.
Note the activated MMP-2 with lower molecular weights in addition to
72 kDa MMP-2 in IL-18-stimulated NK cells-conditioned media. The
data shown are representatives of three independent experiments.
(B,C) Eﬀects of anti-cytokine antibodies on gelatinases secretion from
NK cells. (B) Human NK cells were cultured with IL-18 (100 ng/ml) or
IL-2 (100 IU/ml) in the presence or absence of anti-IL-2 (aIL-2) or
anti-IL-18 (aIL-18) neutralizing antibodies for 24 h. Conditioned
media were analyzed by gelatin zymography. Note the activated
MMP-2 with lower molecular weights in addition to 72 kDaMMP-2 in
IL-18-stimulated NK cells-conditioned media. The data shown are
representatives of two independent experiments. (C) Densitometric
analyses of B are presented as the relative ratio of active form/pro-
form of MMP-2. (D) Eﬀects of anti-IFN-c antibodies on gelatinases
secretion from NK cells. Human NK cells were cultured with IL-18
(100 ng/ml) in the presence or absence of anti-IFN-c neutralizing an-
tibodies (ﬁnal concentrations; 2 lg/ml, 10 lg/ml) for 24 h. Conditioned
media were analyzed by gelatin zymography. Note the activated
MMP-2 with lower molecular weights in addition to 72 kDaMMP-2 in
IL-18-stimulated NK cells-conditioned media. The data shown are
representatives of two independent experiments.
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ditioned media. However, we could not detect MMP-3 and
MMP-13 in NK cell conditioned media with or without IL-18
by immunoblot analysis (data not shown).
3.3. Expression of MT-MMP
MT-MMP, which is expressed on the cell surface, has the
ability to convert the latent form of MMP-2 to the active form
Fig. 4. RT-PCR analysis of mRNA for MT1-MMP in NK cells. Hu-
man NK cells were treated with or without IL-18 (100 ng/ml) for 12 h.
Total RNA was reverse transcribed following PCR ampliﬁcation with
primer for MT1-MMP and b-actin. Ethidium bromide staining of
PCR products. The data shown are representatives of three indepen-
dent experiments.
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cells, we performed immunoblot analysis using a speciﬁc an-
tibody. Cellular lysates prepared from IL-18-stimulated or
unstimulated NK cells were analyzed by immunoblot using
anti-MT1-MMP monoclonal antibodies. As shown in Fig. 3A,
the expression of MT1-MMP was faintly detected in unstim-
ulated NK cells. As shown in Fig. 3A, IL-18 stimulation
induced the expression of MT1-MMP in NK cells in a dose-
dependent manner. This IL-18 induced MT1-MMP expression
on NK cells was completely inhibited by anti-IL-18 antibodies
(Fig. 3B). Although MT2-MMP was also detected in NK cells,
its expression was not aﬀected by IL-18 stimulation (Fig. 3C).
MT3-MMP was not detected in unstimulated or IL-18-stim-
ulated NK cells (data not shown). We also tried to determine
whether IL-18 treatment induces MT1-MMP mRNA expres-
sion in human NK cells using RT-PCR analysis. MT1-MMP
and b-actin cDNA were ampliﬁed by PCR. MT1-MMP
mRNA expression was induced in IL-18-treated NK cells but
not in untreated NK cells. No change was noted in the am-
pliﬁed fragments of the housekeeping gene b-actin (Fig. 4).
3.4. TIMPs secretion from IL-18-treated NK cells
The enzymatic activities of gelatinases are also inﬂuenced by
a family of TIMPs. Therefore, we analyzed the secretion of
TIMPs from IL-18-stimulated NK cells using immunoblot
analysis. Although TIMP-1 and TIMP-2 proteins were iden-Fig. 3. (A,B) Immunoblot analysis of MT1-MMP in IL-18-treated
human NK cells. Human NK cells were cultured with IL-18 in the
presence (B) or absence (A) of anti-IL-18 neutralizing antibodies for 24
h. Blots of SDS–PAGE gels of IL-18-treated NK cell lysates were
probed with antibodies to human MT1-MMP. The data shown are
representatives of three independent experiments. (C) Immunoblot
analysis of MT2-MMP in IL-18-treated human NK cells. Human NK
cells were cultured with IL-18 for 24 h. Blots of SDS–PAGE gels of IL-
18-treated NK cell lysates were probed with antibodies to human
MT2-MMP. The data shown are representatives of two independent
experiments.tiﬁed in NK cells-conditoned media, these secretions were not
altered with or without IL-18 stimulation (data not shown).4. Discussion
IL-18, originally designated as IFN-c inducing factor, is a
cytokine produced by activated macrophages, monocytes,
and dendritic cells during innate immune response [31,32]. IL-
18 has been shown to have the capacity to amplify IFN-c
secretion by NK and NKT cells [25,26]. Although NK cell
numbers are normal in IL-18= mice, NK cell function in-
cluding cytotoxicity has been shown to be signiﬁcantly re-
duced [33]. Collectively, these data demonstrated that IL-18 is
essential for NK cell function. We sought to determine
whether IL-18 enhances NK cell cytotoxicity by inducing
transmigration or interaction with ECM. IL-18 stimulation
signiﬁcantly augments the migration of human NK cells
through a layer of Matrigel by degrading the constituents of
the Matrigel.
The migration of immune cells including T cells has been
previously shown to be mediated by MMPs [34]. MMPs are
members of a family of Zn2þ-dependent endopeptidases and
exhibit full activity for a wide range of connective matrix
proteins [2]. In gelatin zymography, the active form of MMP-2
as well as pro-MMP-2 was detected in IL-18-stimulated NK
cell culture media. MMPs activity is induced by a coordinated
increase in transcription, secretion and proteolytic activation
[35]. During the proteolytic process, latent pro-MMPs are
activated by cleavage of the pro-peptide domain and confor-
mational change of the Zn2þ-binding motif [36]. Various
factors including serine proteinases are known to activate pro-
MMP. However, pro-MMP-2 is unique in that it is not acti-
vated by serine proteinases, but is activated by MT-MMP [22].
MT1-MMP has been identiﬁed as a putative cell membrane-
associated activator of pro-MMP-2 and shown to be expressed
in IL-2-activated NK cells [24].
One of the interesting ﬁndings of the present study is that
pro-MMP-2 is secreted as an active form in IL-18-stimulated
NK cells, suggesting that pro-MMP-2 is activated on NK cells.
Murine IL-2-activated NK cells was shown to express MT1-
MMP by immunoblot analysis [24]. Therefore, we investigated
the expression of MT-MMP in IL-18-stimulated NK cells. Our
data clearly indicated that IL-18 induced MT1-MMP expres-
sion on human NK cells. These data suggest that IL-18-stim-
ulated NK cells not only secrete pro-MMP-2 but also
eﬃciently convert pro-MMP-2 to an active form by expressing
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and MT3-MMP are believed to be tissue activators of pro-
MMP-2 [37], we examined their protein expression on NK cells
by immunoblot analysis. Although MT1-MMP is induced in
IL-18-stimulated NK cells, MT2-MMP, which is constitutively
expressed in NK cells, was not increased by IL-18. The acti-
vation activity of MT3-MMP is much weaker than that of
MT1-MMP [38]. The increase in MT1-MMP protein expres-
sion in NK cells was much larger than that expected from
mRNA. Upregulation of MT1-MMP protein level in IL-18-
treated NK cells occurred at least at the pre-translational level
as shown by the increased MT1-MMP mRNA. However,
additional post-translational regulation cannot be ruled out,
since post-translational upregulation mechanism of MT1-
MMP protein has been described [39].
This is the ﬁrst report demonstrating that IL-18 clearly in-
duced MMP-2 secretion and MT1-MMP expression using
freshly isolated human NK cells. These data suggest that both
gelatinases and MT1-MMP might be biologically important in
the penetration of NK cells through the basal lamina. In
summary, we showed that IL-18 potentiated NK cells’ mi-
gratory ability by inducing MMP-2 production but also by
promoting MMP-2 activation, probably by inducing MT1-
MMP expression. This IL-18-mediated modulation of MMP-2
and MT1-MMP suggests that this cytokine may play a po-
tential role in NK cell migration.References
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